Press Enter to search, Esc to close

Search suggestions

Year invested




Kinapse is a leading global provider of advisory, capability building and operational services to the life sciences industries. The company provides services to the world’s leading life sciences organisations, their customers, suppliers and regulators across a range of specialist areas, including quality and compliance, regulatory and medical affairs, pharmacovigilance and clinical trial disclosure.

Hg partnered with Kinapse in 2016 to support the business in achieving its goal of becoming a market-leading advisory and outsourcing business in a rapidly growing segment of the pharma value chain.

In August 2018,  Kinapse was acquired by Syneos Health, Inc, a leading biopharmaceutical solutions organisation.


Keep up to date with all the latest news from Hg and our portfolio businesses. Sign up for our newsletter…

Click Here